SCD and gastric cancer: Furthermore, Gao et al. discovered that SCD1 regulates cell stemness via the Hippo/YAP pathway, which promotes gastric carcinogenesis, chemo-resistance, and metastasis, and that knocking down SCD1 makes gastric cancer cells responsive to oxaliplatin [70].